Post-obturation Analgesia requirements in patients vaccinated against Covid-19: a short observational study. (preprint)

Aim: To evaluate the need for Post obturation analgesia (acetaminophens) requirements in patients vaccinated against Covid-19, as the role of the NASID’s is still controversial, and the most recommended drug is acetaminophens after Covid-19 Vaccination. Material and Methods: 50 patients vaccinated against Covid-19 undergoing root canal treatments for symptomatic pulpits in molar teeth, were divided into two groups of 25 each on the basis of gender (Group M for males and Group F for females.) Each patient was given a prescription for 650 mg of acetaminophen tablets to be taken 8 hourly with instructions to avail the same only if needed for pain. They were instructed to keep a record of the number of tablets consumed as per record sheet 1, and if the pain did not subside then a stronger analgesic Ketorolac DT 10mg twice a day had to be taken and recorded. In case the pain was accompanied by swelling, the patient was given a prescription of amoxicillin 500mg TDS along with analgesics. Results: In Group M and Group F the mean number of analgesic tablets required was 0.44±0.65, 0.80±1.08 respectively, and the difference was statistically insignificant (p=0.360). The statistical analysis was done by student’s t-test using SPSS (Statistical Package for Social Sciences) Version 20.0 statistical Analysis Software. Conclusion: Within the limitations of this study, this is concluded that acetaminophen is effective in relieving post-obturation pain in patients vaccinated against COVID-19. Keywords: NSAID’s, Acetaminophen, Root Canal Treatment, COVID-19 vaccination, Covisheild

Disaggregating Asian Race Reveals COVID-19 Disparities among Asian Americans at New York City's Public Hospital System (preprint)

There is growing recognition of the burden of COVID-19 among Asian Americans, but data on outcomes among Asian ethnic subgroups remain extremely limited. We conducted a retrospective analysis of 85,328 patients tested for COVID-19 at New York City's public hospital system between March 1 and May 31, 2020, to describe characteristics and COVID-19 outcomes of Asian ethnic subgroups compared to Asians overall and other racial/ethnic groups. South Asians had the highest rates of positivity and hospitalization among Asians, second only to Hispanics for positivity and Blacks for hospitalization. Chinese patients had the highest mortality rate of all groups and were nearly 1.5 times more likely to die than Whites. The high burden of COVID-19 among South Asian and Chinese Americans underscores the urgent needs for improved data collection and reporting as well as public health program and policy efforts to mitigate the disparate impact of COVID-19 among these communities.